Mon, 03 Aug 2026
12:10:46 pm
Rudransh Sangwan
Published at: August 3, 2026, 8:41 AM
Synopsis
LTM shares surged nearly 8% to a three-month high after strong AI revenue growth, rising BlueVerse adoption, outcome-based AI deals, and improving sentiment across the Indian IT sector. Here's why the stock rallied today.

LTM Ltd. shares rallied nearly 8% on Monday, climbing to around ₹4,705 and touching their highest level in three months, as investors responded positively to the company's accelerating artificial intelligence (AI) business. The strong buying interest came after the company highlighted rapid growth in its AI portfolio, increasing enterprise adoption and rising demand for AI-driven digital transformation solutions.
The rally was further supported by improving sentiment across the Indian IT sector, with investors increasingly favouring technology companies that are successfully monetising AI capabilities. Strong peer earnings, healthy deal pipelines and expectations of higher-margin AI projects also boosted confidence in the stock.
Loading chart...
| Particulars | Details |
|---|---|
| Share Price Gain | Nearly 8% |
| Current Share Price | Around ₹4,705 |
| 3-Month High | Yes |
| Key Trigger | Strong AI Business Growth |
| AI Revenue Run Rate | Around $150 Million per Quarter |
LTM shares gained sharply after the company showcased strong traction in its AI-focused business, which has become one of its fastest-growing revenue segments. Management revealed that its AI portfolio, spanning Business AI, Creative AI, and Industrial AI, has reached an annualised quarterly revenue run rate of nearly $150 million.
AI-related services now contribute around 12% of the company's total revenue, highlighting how quickly artificial intelligence is becoming an important growth engine. Investors viewed this as a positive sign that LTM is successfully converting enterprise AI demand into meaningful revenue growth.
| Particulars | Details |
|---|---|
| AI Revenue Run Rate | ~$150 Million (Quarterly Run Rate) |
| Revenue Contribution | Around 12% |
| Key AI Segments | Business AI, Creative AI, Industrial AI |
| Growth Driver | Enterprise AI Adoption |
Another major reason behind the rally is the growing adoption of BlueVerse, LTM's AI platform designed to help enterprises deploy AI solutions across business operations. The company is witnessing increasing demand from clients seeking productivity improvements, automation and AI-powered decision-making tools.
Instead of offering only traditional IT services, LTM is increasingly signing outcome-based AI engagements, where clients pay based on measurable business improvements rather than conventional project billing. Investors see this shift as a positive development because outcome-based contracts generally create stronger customer relationships and can improve long-term profitability.
| Growth Driver | Impact |
|---|---|
| BlueVerse Platform | Enterprise AI Adoption |
| Outcome-Based AI Deals | Higher Value Contracts |
| AI Automation | Productivity Growth |
| Digital Transformation | Increased Client Spending |
The broader Indian information technology sector also remained supportive, with several technology stocks witnessing fresh buying after strong quarterly earnings from industry peers. Investors continue to expect AI-driven spending by global enterprises to remain a major growth driver over the next few years.
Growing confidence in high-margin AI services, improving technology budgets and strong digital transformation demand encouraged investors to rotate into companies with established AI capabilities. LTM benefited from this broader sector optimism alongside its own positive business updates.
While AI remains the biggest growth opportunity, investors will continue tracking whether LTM can further increase AI revenue contribution over the coming quarters. The pace of enterprise AI adoption, new deal wins, platform expansion and management commentary on future demand will remain key indicators for the stock.
Investors will also watch whether AI-led services continue to improve revenue growth and margins as businesses globally increase spending on automation, generative AI and digital transformation initiatives.
| Metric | Why It Matters |
|---|---|
| AI Revenue Growth | Future Earnings Potential |
| BlueVerse Adoption | Enterprise Demand |
| AI Deal Wins | Revenue Visibility |
| Operating Margins | Profitability |
| Quarterly Results | Business Performance |
LTM Ltd. is a global technology consulting and digital engineering company that provides services across cloud computing, artificial intelligence, digital transformation, enterprise software, engineering research and development, data analytics and business process solutions. The company serves clients across industries including manufacturing, banking, healthcare, telecom, retail and technology, with AI becoming one of its fastest-growing strategic business areas.
LTM shares surged nearly 8% after the company reported strong momentum in its AI business, with its AI revenue run rate reaching approximately $150 million per quarter. Positive sentiment across the Indian IT sector also supported the rally.
The primary driver was the company's rapidly expanding artificial intelligence portfolio, including Business AI, Creative AI, and Industrial AI, along with growing enterprise demand for AI-powered digital transformation solutions.
LTM's AI business has reached a quarterly revenue run rate of around $150 million, accounting for approximately 12% of the company's total revenue.
BlueVerse is LTM's AI platform that helps enterprises adopt AI solutions across business operations. Increasing customer adoption of the platform is strengthening the company's AI-led growth strategy.
Outcome-based AI engagements are contracts where clients pay based on measurable business results rather than traditional project billing. These engagements can improve customer retention and support higher-value revenue opportunities.
Yes. Positive quarterly earnings from several IT companies and growing optimism around enterprise AI spending improved investor sentiment across the technology sector, benefiting LTM shares.
LTM provides digital engineering, AI, cloud, and technology consulting services to industries such as manufacturing, banking, financial services, healthcare, retail, telecom, energy, and technology.
Investors should monitor AI revenue growth, BlueVerse platform adoption, new AI deal wins, operating margins, large enterprise contracts, and quarterly financial performance to assess the company's long-term growth prospects.
Yes. AI has become one of LTM's fastest-growing business segments and is increasingly contributing to revenue growth, positioning the company to benefit from rising global enterprise spending on AI technologies.
Investors are optimistic because LTM is successfully expanding its AI capabilities, increasing enterprise adoption, and focusing on high-value AI-driven engagements that could support stronger long-term revenue growth and profitability.

Financial journalist specializing in market analysis, stock research, and investment trends. Dedicated to providing accurate, timely insights for informed decision-making.
Credentials: Experienced financial journalist with expertise in equity markets and economic analysis
The information provided in this article is for educational and informational purposes only and should not be construed as financial, investment, or legal advice. welomoney does not provide personalized investment recommendations.
For detailed terms and conditions, please read our Disclaimer and Terms of Service.

Pine Labs shares jumped over 8% after reporting nearly 20% YoY revenue growth in Q1 FY27 and reaffirming its FY27 revenue guidance of 21% to 23%.

Ethos shares surged nearly 14% after the luxury watch retailer reported strong Q1 FY27 results.

Urban Company shares jumped nearly 18% after reporting strong Q1 FY27 results, with 43.85% revenue growth, narrowing losses, and bullish brokerage...

Shadowfax shares surged over 10% after reporting record Q1 FY27 earnings. Net profit jumped more than eight times to ₹65.

Mankind Pharma shares fell over 4% despite reporting strong Q1 FY27 results, with net profit rising 29.6% and revenue growing 12.9%.